Printer Friendly

Research and Markets: Acute Pain - Pipeline Review, H1 2012.

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/44d04b7d/acute_pain_pipel) has announced the addition of Global Markets Direct's new report "Acute Pain - Pipeline Review, H1 2012" to their offering.

Global Markets Direct's, 'Acute Pain - Pipeline Review, H1 2012', provides an overview of the Acute Pain therapeutic pipeline. This report provides information on the therapeutic development for Acute Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Pain. 'Acute Pain - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Key Topics Covered:

* Introduction

* Global Markets Direct Report Coverage

* Acute Pain Overview

* Therapeutics Development

* An Overview of Pipeline Products for Acute Pain

* Acute Pain Therapeutics under Development by Companies

* Acute Pain Therapeutics under Investigation by Universities/Institutes

* Late Stage Products

* Comparative Analysis

* Mid Clinical Stage Products

* Comparative Analysis

* Early Clinical Stage Products

* Comparative Analysis

* Discovery and Pre-Clinical Stage Products

* Comparative Analysis

* Acute Pain Therapeutics - Products under Development by Companies

* Acute Pain Therapeutics - Products under Investigation by Universities/Institutes

* Companies Involved in Acute Pain Therapeutics Development

* Merck & Co., Inc.

* Pacira Pharmaceuticals, Inc.

* AcelRx Pharmaceuticals, Inc.

* Sun Pharmaceutical Industries Limited

* Anavex Life Sciences Corp.

* NeurogesX, Inc.

* Nuvo Research Inc.

* CombinatoRx, Incorporated

* Applied Pharma Research USA

* Intas Pharmaceuticals Ltd.

* Advinus Therapeutics Pvt. Ltd.

* Transdel Pharmaceuticals, Inc.

* BIOALVO S.A.

* QRxPharma Limited

* Xenome Ltd.

* Iroko Pharmaceuticals, LLC

* Xanodyne Pharmaceuticals, Inc.

* KemPharm, Inc.

* Troikaa Pharmaceuticals Ltd.

* RaQualia Pharma Inc.

* Mt Cook Pharma. Inc.

* Cytogel Pharma, LLC

* Acute Pain - Therapeutics Assessment

* Assessment by Monotherapy Products

* Assessment by Combination Products

* Assessment by Route of Administration

* Assessment by Molecule Type

* Acute Pain Therapeutics - Drug Profile Updates

* Acute Pain Therapeutics - Discontinued Products

* Acute Pain Therapeutics - Dormant Products

* Acute Pain - Product Development Milestones

* Featured News & Press Releases

* Appendix

* Methodology

* Coverage

* Secondary Research

* Primary Research

* Expert Panel Validation

* Contact Us

* Disclaimer

For more information visit http://www.researchandmarkets.com/research/44d04b7d/acute_pain_pipel.

Source: Global Markets Direct
COPYRIGHT 2012 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 27, 2012
Words:525
Previous Article:Graco Announces Scheduled Closing Date for Finishing Brands Acquisition.
Next Article:Research and Markets: Ukraine - Broadband and Digital Media Markets - Insights, Statistics and Forecasts.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters